Dana Farber ( Dana Farber)

Primary tabs

Dana Farber's picture

Management

Contact Address

About Dana Farber

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Dana Farber press release, blog etc

Sat, 02/01/2025 - 00:11 Four new members elected to Dana-Farber Cancer Institute Board of Trustees
Thu, 01/30/2025 - 23:22 AI model learns generalized language of regulatory genomics, predicts cellular stories
Tue, 01/28/2025 - 23:27 More than 145 Dana-Farber affiliated faculty named as 2025 Top Doctors in Boston Magazine
Mon, 01/27/2025 - 17:40 Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
Fri, 01/24/2025 - 18:10 Dana-Farber investigators pinpoint keys to cell therapy response for leukemia
Sun, 01/19/2025 - 23:21 Phase 2 LITESPARK-003 results suggest continued study of novel first-line combo for advanced kidney cancer
Mon, 01/13/2025 - 18:51 Dana-Farber and Gustave Roussy announce 2025 Transatlantic Exchange scientific program to focus on Radioligand Therapy
Wed, 08/14/2024 - 16:25 New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune Response
Thu, 08/08/2024 - 19:57 FDA approves new therapy for glioma patients for first time in decades
Tue, 07/23/2024 - 19:15 Dana-Farber's Edward Chouchani selected as a Howard Hughes Medical Institute Investigator
Tue, 07/16/2024 - 04:15 U.S. News & World Report names Dana-Farber Brigham Cancer Center among nation's best for 2024-2025
Mon, 07/15/2024 - 00:33 Specially equipped natural killer cells show effectiveness against the most common form of ovarian cancer
Thu, 07/11/2024 - 19:10 Jose Cancelas named director of the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Wed, 07/10/2024 - 23:16 Study highlights the importance of infection prevention after CAR T-cell therapy
Thu, 06/27/2024 - 23:50 Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds
Tue, 06/18/2024 - 23:16 New guidelines for radiation therapy for HPV-associated head and neck cancer
Tue, 06/18/2024 - 23:15 Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients
Mon, 06/17/2024 - 23:51 Dana-Farber patient with breast cancer hosts new 'Chemo Coffee Talk' podcast from infusion chair
more

InfoBox

HomePagewww.dana-farber.org
Facebookwww.facebook.com/danafarbercancerinstitute
Twittertwitter.com/danafarber
YouTubewww.youtube.com/user/DanaFarberCancerInst
Google+plus.google.com/114201765956539393893?prsrc=3
Instagraminstagram.com/danafarber
Pinterestpinterest.com/DFCI
LinkedInwww.linkedin.com/company/dana-farber-cancer-institute
Wikipediaen.wikipedia.org/wiki/Dana%E2%80%93Farber_Cancer_Institute